published meta-analysis   sensitivity analysis   studies

Vitamin D in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsEntrenas (Pilot Calcifediol), 2020 0.12 [0.01; 2.79] Murai, 2020 1.36 [0.46; 4.04] 0.65[0.07; 5.74]Entrenas (Pilot Calcifediol), 2020, Murai, 2020251%316moderatenot evaluable ICU admissiondetailed resultsEntrenas (Pilot Calcifediol), 2020 0.03 [0.00; 0.27] Murai, 2020 0.71 [0.37; 1.38] 0.18[0.01; 3.85]Entrenas (Pilot Calcifediol), 2020, Murai, 2020286%316moderatenot evaluable0.02.01.0relative treatment effectwww.metaEvidence.org2021-01-22 19:47 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 734 - roots T: 290